EN
- Bifidobacterium longum CCFM760
- Lactobacillus plantarum CCFM1143
- Bacillus coagulans CCFM1041
- Saccharomyces boulardii HS5
- 1) Promotes digestion, improves constipation and odor, regulates immunity
- 2) Regulates the gastrointestinal tract, improves feed intake, improves soft stools
- 3) Relieve diarrhea caused by ETEC, regulates the balance of intestinal flora
HelpGut® Pet Health - Gut Health
Formulation
Functionality
Scientific Support
Human clinical trial
1) Evaluation of the Clinical Alleviation Effect of Bacillus coagulans CCFM1041 on Patients with Functional Constipation.
Pre-clinical paper
1) Yang B, Yue Y, Chen Y, Ding M, Li B, Wang L, Wang Q, Stanton C, Ross RP, Zhao J, Zhang H, Chen W. Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study. Front Immunol. 2021 Oct 15;12:746585. doi: 10.3389/fimmu.2021.746585. PMID: 34721416; PMCID: PMC8555466.
2) Jiang Cao, Wenyin Liu, Ruolan Liliu, Jianxin Zhao, Hao Zhang, Wei Chen, Qixiao Zhai, MLST analysis of genetic diversity of Bacillus coagulans strains to evaluate effects on constipation model,Food Science and Human Wellness,Volume 11, Issue 4,2022,Pages 815-827,ISSN 2213-4530.
3) Jiang Cao, Leilei Yu, Jianxin Zhao, Hao Zhang, Wei Chen, Yuzheng Xue, Qixiao Zhai, Alleviative effects of Bacillus coagulans strains on IBS-unraveling strain specificity through physiological and genomic analysis, Food Science and Human Wellness, Volume 13, Issue 4, 2024, Pages 1845-1855, ISSN 2213-4530.
Patent
1) Jiangnan University, A strain of Bifidobacterium longum and its application, Chinese Invention Patent, Granted Publication Number CN107893044B.
2) Jiangnan University, Lactobacillus plantarum capable of relieving ETEC (enterotoxigenic enterobacteria) induced diarrhea and application thereof, Chinese Invention Patent, Granted Publication Number CN112239739A.
3) Jiangnan University, Bacillus coagulans for improving relative abundance of actinomycota in intestinal tract and inhibiting expression quantity of proinflammatory factors, Chinese Invention Patent, Granted Publication Number CN114908023B.